Research Article
Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study
Figure 1
Flowchart for the study. DPP-4i: dipeptidyl peptidase-4 inhibitor; IDegLira: insulin degludec/liraglutide.